Lv7
5008 积分 2021-08-23 加入
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
1个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
7个月前
已完结
Complement-secreting CAFs are associated with better prognosis in pancreatic cancer: single-cell multiomics
8个月前
已完结
Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy
11个月前
已关闭
皖公网安备34019202002308
